BSE filing, BSE: 544694. Summary written from the filing by ALFA Finder's alert engine.
Accretion Nutraveda Ltd: key numbers
- Share price
- ₹290.00
- Market cap
- ₹210.0 Cr
- Revenue (annual)
- ₹33.60 Cr
- Net profit (annual)
- ₹5.07 Cr
- P/E (TTM)
- 41.4×Sector 46.1×
- Promoter holding
- 73.48%+0.00% QoQ
- FII holding
- 1.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Accretion Nutraveda Ltd
All →Accretion Nutraveda Board Meeting Date
Accretion Nutraveda will hold a board meeting on 31 October 2026 to consider unaudited financial results for the half year ended September 2026. The intimation is a prior notice under Regulation 29.
Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited announced results of its postal ballot. Shareholders approved special resolutions regarding MOA alteration, borrowing limits, and various loan and guarantee authorizations.
Accretion Nutraveda Other Announcement
Accretion Nutraveda Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory disclosure under SEBI LODR.
Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited issued a Notice of Postal Ballot to seek shareholder approval for the alteration of its Memorandum of Association. Voting concludes on October 9, 2026.
Accretion Nutraveda Board Meeting Outcome
Accretion Nutraveda's board approved altering its Object Clause to include nutraceuticals and hospitals. The board also proposed increasing borrowing limits and advancing loans to related entities.
Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited held its 5th Annual General Meeting on 27th August, 2026, where shareholders transacted routine business, including the adoption of financial statements.
Other other announcement announcements
All →Milky Mist Dairy Food Other Announcement
Milky Mist's board appointed B Chandra & Associates as Secretarial Auditors for FY 2026-27 to 2030-31. Shareholder approval is pending at the ensuing AGM.
- Execution
- FY 2026-27 to FY 2030-31 (five years)
Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd, an SME-platform listed company, confirms non-applicability of Corporate Governance under Regulation 27(2) for the quarter ended 30 September 2026. A Company Secretary certificate is enclosed.
Wipro Other Announcement
Wipro disclosed a designated person's 34,200-share ADR sale worth about ₹0.67 Crore on 28 October 2026. The sale followed RSU exercise, leaving 60,266 securities held.
- Value
- ₹0.67 Cr
OK Play India Other Announcement
OK Play India filed its quarterly shareholding pattern for the quarter ended September 2026. It shows category holdings only, with no transaction.
Spice Islands Industries Other Announcement
Spice Islands Industries filed a Reg 32 statement reporting no deviation in preferential issue fund utilization for Q3 FY27. The ₹8.70 Crore raise is fully deployed.
Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.